Fbr & Co (FBRC) 21.29 $FBRC FBR's (FBRC) CEO Richard

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Fbr & Co (FBRC) 21.29 $FBRC

FBR's (FBRC) CEO Richard Hendrix on Q1 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Wed Apr 22, 9:27AM CDT

FBRC: 21.29 (-0.10)

FBR reports 1Q loss
Automated Insights - Tue Apr 21, 3:58PM CDT
ARLINGTON, Va. (AP) _ FBR & Co (FBRC) on Tuesday reported a first-quarter loss of $2.5 million, after reporting a profit in the same period a year earlier.
FBRC: 21.29 (-0.10)

FBR misses by $0.38, misses on revenue
Seeking Alpha - at Seeking Alpha - Tue Apr 21, 3:17PM CDT

FBRC: 21.29 (-0.10)

FBR & Co. Reports First Quarter 2015 Financial Results
GlobeNewswire - Tue Apr 21, 3:06PM CDT
Financial Results for the three months ended March 31, 2015:
FBRC: 21.29 (-0.10)

FBR to Report First Quarter Financial Results
GlobeNewswire - Wed Apr 08, 3:05PM CDT
FBR & Co. (Nasdaq:FBRC) (FBR), a leading investment bank serving the middle market, announced today that it will release results for the first quarter of 2015 before the market opens on Wednesday, April 22, 2015.
FBRC: 21.29 (-0.10)

FBR Adds Senior Bankers in Healthcare and Financial Institutions Groups
GlobeNewswire - Tue Mar 31, 3:30PM CDT
FBR & Co. (Nasdaq:FBRC) (FBR), a leading investment bank serving the middle market, announced the hiring of Messieurs Eric M. Corrigan as Managing Director, Financial Institutions, and John W. Patterson as Managing Director, Healthcare. Mr. Corrigan will be covering depository institutions, primarily in the southeastern United States. Mr. Patterson will be covering companies in the healthcare services sector. Both will be based in FBR's New York office.
FISI: 23.73 (-0.44), FBRC: 21.29 (-0.10)

FBR Adds Senior Analyst to Healthcare Practice
GlobeNewswire - Tue Feb 17, 11:30AM CST
FBR & Co. (Nasdaq:FBRC) (FBR), a leading investment bank serving the middle market, announced the hiring of Christopher S. James, M.D., as Senior Vice President, Senior Research Analyst in its Equity Research Department. Dr. James will be based in New York and will focus on the biotech sector.
FBRC: 21.29 (-0.10)

FBR & Co's (FBRC) CEO Rick Hendrix on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Wed Feb 11, 12:07PM CST

FBRC: 21.29 (-0.10)

FBR posts 4Q profit
Automated Insights - Tue Feb 10, 6:51PM CST
ARLINGTON, Va. (AP) _ FBR & Co (FBRC) on Tuesday reported fourth-quarter earnings of $932,000.
FBRC: 21.29 (-0.10)

FBR beats by $0.09, misses on revenue
Seeking Alpha - at Seeking Alpha - Tue Feb 10, 4:21PM CST

FBRC: 21.29 (-0.10)

FBR Reports Fourth Quarter and Full Year 2014 Financial Results
GlobeNewswire - Tue Feb 10, 4:15PM CST
FBR & Co. (Nasdaq:FBRC) ("FBR" or the "Company", a leading investment bank serving the middle market, today reported net after-tax earnings of $17.0 million, or $1.48 per diluted share for the year ended December 31, 2014, compared to net after-tax earnings of $92.9 million, or $7.17 per diluted share in 2013. Pretax income for 2014 was $17.4 million on revenue of $182.1 million compared with $57.3 million on revenue of $259.8 million in 2013.
FBRC: 21.29 (-0.10)

FBR (FBRC) Downgraded From Buy to Hold
at The Street - Wed Feb 04, 11:00AM CST
FBR (FBRC) has been downgraded by TheStreet Ratings from Buy to Hold with a ratings score of C.
FBRC: 21.29 (-0.10)

FBR to Report Fourth Quarter and Full Year 2014 Financial Results
GlobeNewswire - Wed Jan 28, 3:08PM CST
FBR & Co. (Nasdaq:FBRC) (FBR), a leading investment bank serving the middle market, announced today that it will release results for the fourth quarter and full year of 2014 before the market opens on Wednesday, February 11, 2015.
FBRC: 21.29 (-0.10)

Raymond James Reports In-Line Q1 Earnings, Up YoY - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jan 22, 9:40AM CST
Raymond James (RJF) announced fiscal first-quarter 2015 earnings results yesterday after the market closed. The company reported earnings per share of 87 cents, in line with the Zacks Consensus Estimate.
IBKR: 34.49 (+0.29), RJF: 57.06 (-0.50), FBRC: 21.29 (-0.10), SCHW: 30.12 (-0.38)

FBR Further Builds Healthcare Practice
GlobeNewswire - Wed Jan 14, 3:38PM CST
FBR & Co. (Nasdaq:FBRC) (FBR), a leading investment bank serving the middle market, announced the hiring of Edward P. White as Senior Vice President, Senior Research Analyst in its Equity Research Department. Mr. White will be based in New York and will focus on the biotech sector.
FBRC: 21.29 (-0.10)

FBR Announces 21st Annual Investor Conference
GlobeNewswire - Wed Nov 26, 8:00AM CST
FBR & Co. (Nasdaq:FBRC) (FBR), a leading investment bank serving the middle market, will host its 21st Annual Fall Investor Conference in New York at The Grand Hyatt on Tuesday, December 2, 2014. Institutional investors will have one-on-one opportunities with roughly 100 companies that span the financial, insurance, real estate, and industrial sectors. In addition, there will also be two mortgage REIT panels with industry leading executives.
FBRC: 21.29 (-0.10)

Falling Earnings Estimates Signal Weakness Ahead for FBR & Co - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Oct 31, 7:53AM CDT
It may not be a good decision to keep FBR & Co in your portfolio as it witnessed a significant price decline and has seen negative earnings estimate revisions
FBRC: 21.29 (-0.10)

Nasdaq stocks posting largest percentage decreases
AP - Fri Oct 24, 5:35PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at the close of trading:
AMZN: 445.10 (+55.11), TESS: 27.10 (+0.72), HUBG: 40.91 (+3.22), SYNA: 85.69 (-3.35), LAYN: 5.79 (+0.27), LAKE: 9.69 (-0.19), EGOV: 17.63 (-0.11), FBRC: 21.29 (-0.10)

FBR's (FBRC) CEO Rick Hendrix on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Oct 23, 6:05PM CDT

FBRC: 21.29 (-0.10)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Lilly's Retatrutide Outshines Ozempic in Key Diabetes Trial

Updated Category News Views 15

Lilly's Breakthrough in Diabetes Treatment Eli Lilly's retatrutide is stirring up the diabetes treatment waters. The latest Phase 3 comparison to Ozempic's top dose reveals some surprising results. I'm not one to toss out kudos lightly, but this could be a genuine game-changer if things hold steady. A1C Reductions: A Close Look at the Numbers We’re staring down the...

Continue Reading
Radiation Oncologist Dr. Pennock Honored: A Closer Look

Updated Category News Views 10

An Honor from The Inner Circle Sometimes, in a field stuffed with brilliant minds, a beacon stands out. That's Dr. Michael M. Pennock for you—a man who doesn’t just treat cancer patients but transforms their journeys with precision and empathy. Recognized as a Pinnacle Lifetime Member by The Inner Circle, Pennock’s dedication in the field of radiation oncology is...

Continue Reading
Infection Control Market Set for Explosive Growth by 2031

Updated Category News Views 35

Untangling the Surge in Infection Control Demand Lately, it's like every healthcare joint worldwide is scrambling for better infection control. We're talking about a market poised to jump from a whopping USD 58.5 billion in 2026 to USD 80.2 billion by 2031—a tidy 37% uptick. That change, brewing at a 6.5% CAGR, speaks volumes about where the industry's heading. What's...

Continue Reading
CashNetUSA Faces Class Action Over Exploitative Rates

Updated Category News Views 0

High-Risk Lending Meets Military Protections Ever seen a seemingly legal scheme that just leaves a sour taste? That's the vibe with CashNetUSA right now. They've landed in the hot seat over allegedly sky-high interest rates served up to folks who put on a uniform. We're talking about a proposed nationwide class action lawsuit accusing the lender of giving active-duty...

Continue Reading
Danobatgroup's New HQ in Shanghai Marks Strategic Shift

Updated Category News Views 83

Shanghai Beckons: A Game Changer for Danobatgroup One crisp morning in Shanghai marks a turning point for Danobatgroup. The Spanish heavy-hitter in machine tools has pinpointed the Shanghai Xinzhuang Industry Park in Minhang District for its Asia-Pacific headquarters. It ain't just another blip on the radar—this one's a calculated leap. Location, Location, Location...

Continue Reading
FluxCap Launches: Empowering Lawyers with Dynamic Tech

Updated Category News Views 54

A Fresh Force in Legal Tech: FluxCap Debuts Alright, strap in because the legal world just got itself a new team in the majors. FluxCap is breaking out into the open, promising to shake up how big, gnarly cases get tackled. These aren't just any cases; we're talking the kind that keep antitrust knuckles white and palms sweaty. It's like watching seasoned racecar drivers...

Continue Reading
Clip Expands Horizons with Pulpos Acquisition, New Board Member

Updated Category News Views 84

Clip's Strategic Move with Pulpos Clip just laid down a serious marker in the digital payment world by snagging Pulpos, a firm that’s got its claws deep into AI-driven business management software. This move isn't just some fancy headline. It's a real, grounded step in expanding Clip's ecosystem to bolster the backbone of Mexico's economy: small and medium-sized...

Continue Reading
Innovative Trial Targets Drug Resistance in Lung Cancer

Updated Category News Views 53

The Battle Against Drug Resistance Heats Up Folks, we're in a never-ending fight here against one of the toughest adversaries out there: lung cancer. And lemme tell ya, when drugs show resistance, it's like trying to punch a ghost. But there’s a fresh wind blowing, as Dr. Bobak Parang steps up to the plate with a $620K grant aimed squarely at tackling drug resistance in...

Continue Reading
Sony's LYTIA 720 Image Sensor: A Game Changer?

Updated Category News Views 88

Unpacking Sony's Latest Sensor: LYTIA 720 Tell me, when was the last time a tech drop made you shake your head in awe? Sony just pulled one of those moves with their latest toy, the LYTIA 720. We're talking a 50-effective megapixel CMOS image sensor crafted for mobile warriors, and it packs a punch that should have the competition looking over their shoulder. Dazzling...

Continue Reading
Civitas Boosts Orlando Luxury Hotel with $386M Loan

Updated Category News Views 0

Orlando Sets the Stage for Luxury Expansion Well, it seems Orlando's hospitality scene is about to get a significant bump. Civitas Capital Group just tossed a cool $386 million into the pot for the construction of a 700-key luxury hotel on the infamous International Drive. We're not talking about just another hotel here; this one's a real beast, a future InterContinental...

Continue Reading

Top 5 Most Recently Viewed Articles

Orbit Garant's First Quarter 2026 Performance Reviewed

Updated Category News Views 157

Overview of Financial Performance Orbit Garant Drilling Inc. (TSX: OGD) has released its financial results for the first quarter of fiscal 2026, ending on September 30, 2025. During this three-month period, the company recorded a revenue of $46.7 million, marking a 3.7% decline compared to $48.4 million during the same period last year. The revenue figures reflect a range...

Continue Reading
Celebrating Leadership Excellence at Coldwell Banker 2025

Updated Category News Views 250

Celebrating Achievements in Real Estate Leadership The Leadership Awards highlight the dedication of Coldwell Banker-affiliated real estate professionals who embody the core values of the organization. Recognizing Outstanding Contributions With a strong commitment to innovation and community service, Coldwell Banker Real Estate LLC, a subsidiary of Anywhere Real Estate...

Continue Reading
U.S. Drone Production Boost Promises Growth for Key Companies

Updated Category News Views 167

Major Shift in U.S. Drone Production Policies The recent announcement from the U.S. Defense Secretary has ignited excitement in the drone manufacturing industry. On a significant day, the Secretary unveiled plans to fast-track drone production through reforms aimed at simplifying procurement processes within the Pentagon. This bold move signifies a departure from previous...

Continue Reading
Acacia Research Set for Q3 2024 Financial Results Release

Updated Category News Views 96

Exciting Announcement from Acacia Research Acacia Research Corporation (NASDAQ: ACTG) is poised to share its financial outcomes for the third quarter of 2024. This revelation is set to occur before the market opens on a significant day in November. Businesses and investors alike are eager to gain insights into the company’s latest financial endeavors. What to Expect...

Continue Reading
Revolutionizing Grocery Shopping: Deliverect's New Retail Solution

Updated Category News Views 185

Revolutionizing Grocery Retail with Deliverect's Innovative Solution Deliverect, a leader in food technology software as a service (SaaS), has introduced Deliverect Retail to enhance the digital shopping experience for groceries. This important development allows grocery retailers to operate more effectively, which leads to better sales and improves customer satisfaction....

Continue Reading